Tandem Diabetes Care, Inc.TNDMNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank38
3Y CAGR+13.7%
5Y CAGR-35.2%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
+13.7%/yr
vs -64.6%/yr prior
5Y CAGR
-35.2%/yr
Recent acceleration
Acceleration
+78.3pp
Accelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.74% |
| Q3 2025 | -0.12% |
| Q2 2025 | -5.03% |
| Q1 2025 | -4.70% |
| Q4 2024 | 1.04% |
| Q3 2024 | 2.16% |
| Q2 2024 | -0.38% |
| Q1 2024 | -1.22% |
| Q4 2023 | 1.36% |
| Q3 2023 | -0.71% |
| Q2 2023 | -0.78% |
| Q1 2023 | -9.37% |
| Q4 2022 | 0.50% |
| Q3 2022 | 1.06% |
| Q2 2022 | 2.10% |
| Q1 2022 | 12.17% |
| Q4 2021 | 6.45% |
| Q3 2021 | 6.92% |
| Q2 2021 | 5.43% |
| Q1 2021 | 5.28% |
| Q4 2020 | 6.45% |
| Q3 2020 | 9.21% |
| Q2 2020 | 79.49% |
| Q1 2020 | 5.28% |
| Q4 2019 | 11.43% |
| Q3 2019 | 14.73% |
| Q2 2019 | 18.81% |
| Q1 2019 | 4.07% |
| Q4 2018 | 13.59% |
| Q3 2018 | 14.94% |
| Q2 2018 | 9.19% |
| Q1 2018 | 51.76% |
| Q4 2017 | 8.38% |
| Q3 2017 | -10.72% |
| Q2 2017 | -12.57% |
| Q1 2017 | 0.29% |
| Q4 2016 | 24.42% |
| Q3 2016 | -17.27% |
| Q2 2016 | -9.49% |
| Q1 2016 | -3.58% |